A.I.M. Interview: Algenol’s CEO Paul Woods

A.I.M. Interview: Algenol’s CEO Paul Woods

“The conclusions from the Aquatic Species Program are not correct,” says Algenol CEO Paul Woods, taking issue with the 1980’s assessment that photobioreactors cannot be a cost effective means…

New Anesthetic Derived From Algae

In a randomized, double-blind trial, patients given neosaxitoxin, a new local anesthetic derived from algae, had significantly less postoperative pain and recovered about two days sooner than those given…

Special Report: Spirulina Part 1 Origins and Biology

Special Report: Spirulina Part 1 Origins and Biology

Spirulina is the immortal descendent of the first photosynthetic life form. Beginning 3.5 billion years ago, blue-green algae created our oxygen atmosphere so other life could evolve. Since then, algae…

Algae 101 Part 21—Job Creation in the Algae Industry

Algae 101 Part 21—Job Creation in the Algae Industry

Political, social and business leaders agree on relatively little but they are aligned in promoting job creation. President Obama holds high profile meetings with industry leaders such as…

The Other Big Issue in Scaling Up: Land Use Permission

The Other Big Issue in Scaling Up: Land Use Permission

Picture this: the CEO of a large algal biomass corporation wants to pursue a new development. The economic difficulties haven’t slowed his company so he decides to build a new biorefinery near a small…

USDA Rates Feedstocks for Biofuels

From Cole Gustafson, Biofuels Economist at NDSU Extension Service comes a story in the Western Farm Press that a US Department of Agriculture-funded study is developing new pricing…

A.I.M. Interview: Ben Cloud, CEO, Phyco BioSciences

A.I.M. Interview: Ben Cloud, CEO, Phyco BioSciences

Ben Cloud had a radical idea. Coming from an agricultural background that included 17 years as president and CEO of Western Agri-Group—a diversified farming enterprise comprising 4500 acres…